UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000050749
Receipt number R000057674
Scientific Title Multicenter Observational Study to Evaluate Epidemiology, Diagnosis, and Treatment of Disseminated Intravascular Coagulation
Date of disclosure of the study information 2023/04/02
Last modified on 2023/04/02 14:30:32

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Multicenter Observational Study to Evaluate Epidemiology, Diagnosis, and Treatment of Disseminated Intravascular Coagulation

Acronym

Multicenter Observational Study for Disseminated Intravascular Coagulation

Scientific Title

Multicenter Observational Study to Evaluate Epidemiology, Diagnosis, and Treatment of Disseminated Intravascular Coagulation

Scientific Title:Acronym

Multicenter Observational Study for Disseminated Intravascular Coagulation

Region

Japan


Condition

Condition

Critically ill patients

Classification by specialty

Medicine in general Hematology and clinical oncology Infectious disease
Surgery in general Emergency medicine Intensive care medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate epidemiology, diagnosis, and treatment of disseminated intravascular coagulation

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Short-term mortality (28day from admission, ICU discharge, hospital discharge)

Key secondary outcomes

Bleeding complication, multi-organ dysfunction, duration of mechanical ventilation, duration of dialysis, duration of catecholamine use, changes in laboratory data


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Participants requiring emergency hospitalization or ICU admission

Key exclusion criteria

Patients considered inappropriate for this study by the investigators

Target sample size

15000


Research contact person

Name of lead principal investigator

1st name Kazuma
Middle name
Last name Yamakawa

Organization

Osaka Medical and Pharmaceutical University

Division name

Department of Emergency and Critical Care Medicine

Zip code

569-8686

Address

2-7 Daigakumachi, Takatsuki, Osaka, Japan

TEL

0726831221

Email

kazuma.yamakawa@ompu.ac.jp


Public contact

Name of contact person

1st name Kazuma
Middle name
Last name Yamakawa

Organization

Osaka Medical and Pharmaceutical University

Division name

Department of Emergency and Critical Care Medicine

Zip code

569-8686

Address

2-7 Daigakumachi, Takatsuki, Osaka, Japan

TEL

0726831221

Homepage URL


Email

kazuma.yamakawa@ompu.ac.jp


Sponsor or person

Institute

Osaka Medical and Pharmaceutical University

Institute

Department

Personal name

Kazuma Yamakawa


Funding Source

Organization

The Japanese Society on Thrombosis and Hemostasis

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Osaka Medical and Pharmaceutical University

Address

2-7 Daigakumachi, Takatsuki, Osaka, Japan

Tel

0726831221

Email

kazuma.yamakawa@ompu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 04 Month 02 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2023 Year 03 Month 01 Day

Date of IRB

2023 Year 03 Month 08 Day

Anticipated trial start date

2023 Year 04 Month 01 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This multicenter observational study evaluates the epidemiology, diagnosis, and treatment of disseminated intravascular coagulation. Medical data such as electrical clinical records, critical care department systems, and DPC data will be used to generate an integrated multicenter database. Clinical data will be collected prospectively and comprehensively, and retrospectively analyzed for resolving various clinical questions.


Management information

Registered date

2023 Year 04 Month 02 Day

Last modified on

2023 Year 04 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000057674


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name